Clinical Trial: A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07650357) titled 'A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)' on June 08.

Brief Summary: Phase 1, open-label, multicenter study to evaluate the safety, tolerability, PK, PD, and preliminary clinical activity of CLSP 5282 when administered to HLA A*03:01-positive adult patients with advanced solid tumors that harbor the KRas G12V mutation.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor Non Small Cell Lung Cancer Pancreatic Carcinoma Colorectal Cancer

Intervention: DRUG: CLSP-5282

CLSP-5282 to be administered by IV infusion

Recruitment Status: NOT_YET_REC...